PURPOSE: To describe the clinical manifestations of @entity5278 presumed to be secondary to allogenic bone marrow transplantation after development of self-tolerance to @entity2132 ( @entity2132 ). METHODS:                 <AbstractText Label="CASE REPORT" NlmCategory="METHODS">A 17-year-old male who received an allogenic bone marrow transplant (BMT) from his HLA-identical sister. RESULTS: One year after BMT, grade II chronic @entity2132 developed. Two years later, vision deteriorated to 20/50 R.E. and 20/400 L.E. Ophthalmoscopic examination showed multiple chorioretinal punched-out scars throughout the posterior pole and mid-periphery of both eyes. Fluorescein angiography showed four @entity1940 ( @entity1940 ) in the right eye that were surgically removed, and a @entity735 . CONCLUSIONS: @entity5278 is a possible complication related to allogenic BMT. It should be included as a late cause of BMT-associated choroidopathy. Surgical removal of vision-threatening @entity1940 is a reasonable approach. (Eur J Ophthalmol 2002; 12: 135-7).

XXXX after allogenic bone marrow transplantation.

@entity735 :: ('MESH:D005124', 'Disease') :: ['subfoveal disciform scar in the left eye'] @entity1940 :: ('MESH:D020256', 'Disease') :: ['CNVMs', 'choroidal neovascular membranes'] @entity2132 :: ('MESH:D006086', 'Disease') :: ['GVHD', 'chronic graft-versus-host disease'] @entity5278 :: ('MESH:C537374', 'Disease') :: ['Multifocal choroiditis', 'multifocal choroiditis']
@entity5278 :: (MESH:C537374,Disease) :: ['Multifocal choroiditis']
